Article Text
Editorial commentary
Treating adults with spinal muscular atrophy with nusinersen
Statistics from Altmetric.com
Footnotes
Twitter @imichellefarrar
Contributors MAF and MK planned, drafted and revised the manuscript. All authors read and approved the submitted version.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned; internally peer reviewed.